BDI "Ellison to Participate in ASCO GI Symposium... Exploring Investment and Collaboration Opportunities"

[Asia Economy Reporter Hyunseok Yoo] VIDI announced on the 12th that its subsidiary Ellison plans to attend the ‘ASCO GI Symposium 2022 (American Society of Clinical Oncology Gastrointestinal Symposium 2022)’ held in San Francisco, USA.

Ellison is planning a separate side event at this symposium because many key decision-makers in the bio industry will gather, and intends to actively seek investment and collaboration opportunities.

ASCO (American Society of Clinical Oncology) is the most prestigious society in oncology, with over 40,000 participants. Leading researchers from around the world gather not only to present their research achievements from the past year but also because major global pharmaceutical and bio companies participate, numerous meetings and information exchanges take place.

The ASCO GI Symposium provides the latest information on science that is changing the latest practices in gastric cancer treatment. According to the company, it is an opportunity to interact with global experts in the gastric cancer field through processes discussing face-to-face networking, mentoring, and strategy focused on the latest solutions.

At this symposium, Ellison plans to meet with clinical trial practitioners of ‘Glufosfamide,’ a pancreatic cancer treatment currently in Phase 3 clinical trials, and preliminary Phase 2 clinical trial practitioners of ‘ILC,’ a lung cancer treatment to be conducted in the future, to exchange detailed information and cooperate to expedite clinical progress.

A company official said, “This event is scheduled to be held in San Francisco, where collaboration with excellent IT personnel from Silicon Valley is active,” adding, “Investors specializing in healthcare are concentrated mainly in the western United States, which will also help attract investment.”

He continued, “Following participation in the ASCO GI Symposium, Ellison also plans to attend the JP Morgan Health Conference, which is scheduled to be held in San Francisco next year, just like the ASCO GI Symposium,” and added, “The JP Morgan Health Conference is an event where major global investors gather in one place, and since it is an investment conference centered on CEO presentations, it is a highly likely event to attract investment.”